← Research.Patient.info
Browse research by treatment
1,000 treatments and interventions are being studied right now — from new medicines to therapies, devices and lifestyle programmes.
- Placebo6531191
- Pembrolizumab107213
- Carboplatin67139
- Cisplatin55118
- Paclitaxel43108
- Dexamethasone4788
- Cyclophosphamide4085
- Durvalumab3381
- Gemcitabine4177
- Nivolumab3274
- Bevacizumab4473
- Docetaxel3470
- Atezolizumab2367
- Pemetrexed2966
- Rituximab2666
- Lenalidomide1958
- No intervention4958
- Capecitabine2652
- Oxaliplatin2852
- Doxorubicin2648
- Prednisone2044
- Standard of Care2643
- Daratumumab2241
- MRI3340
- Nab-paclitaxel1839
- Questionnaires3439
- blood sample3038
- Venetoclax2037
- Fludarabine1837
- Pomalidomide1836
- Biospecimen Collection1936
- Magnetic resonance imaging2035
- Olaparib1334
- Bortezomib1233
- Fulvestrant1433
- Irinotecan2032
- Enzalutamide1432
- Tocilizumab1731
- Radiotherapy1431
- Etoposide1531
- Cetuximab2031
- Obinutuzumab1230
- Vincristine1430
- Leucovorin1930
- Letrozole1328
- Radiation therapy1028
- Questionnaire2628
- Abemaciclib1028
- Temozolomide1427
- Trastuzumab1226
- blood sampling2426
- Trastuzumab deruxtecan1525
- Computed Tomography1125
- Ribociclib1424
- Palbociclib724
- Exercise1724
- Everolimus1123
- Fluorouracil1223
- Control1523
- Usual Care1623
- Semaglutide822
- Ruxolitinib922
- Acalabrutinib821
- azacitidine1221
- Epcoritamab421
- Rilvegostomig1721
- Quality-of-Life Assessment721
- Questionnaire Administration921
- Sacituzumab tirumotecan1521
- Cabozantinib821
- Dostarlimab920
- Carfilzomib920
- Tirzepatide1319
- Cytarabine919
- Lenvatinib519
- Data Collection1519
- Ipilimumab919
- 5-fluorouracil1418
- Amivantamab818
- risankizumab818
- Upadacitinib618
- Inavolisib1018
- Exemestane818
- Pumitamig1818
- Teclistamab818
- Bendamustine918
- Laboratory Biomarker Analysis218
- CEMIPLIMAB918
- Guselkumab717
- Topotecan1017
- Osimertinib317
- Baricitinib1417
- Methotrexate716
- Niraparib616
- PREDNISOLONE1216
- The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.716
- This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.716
- Chemotherapy916
- Anastrozole616
- Tremelimumab516
- Observation1216
- Zanubrutinib616
- Dupilumab516
- Avelumab415
- Midazolam915
- Trametinib615
- Belzutifan615
- Methylprednisolone614
- Rescue medication1414
- Abiraterone acetate414
- Blood samples1214
- Sunitinib714
- The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.414
- Ibrutinib513
- Metformin713
- Tamoxifen513
- Pirtobrutinib713
- Glofitamab613
- Talquetamab613
- Vinorelbine613
- Apalutamide412
- Matching placebo712
- Elranatamab912
- Abiraterone712
- Control Group1012
- Mirikizumab812
- Ocrelizumab212
- Positron Emission Tomography812
- bimekizumab812
- KEYTRUDA 25 mg/mL concentrate for solution for infusion612
- Volrustomig711
- Belantamab mafodotin411
- Deucravacitinib411
- Sonrotoclax711
- IMVT-1402811
- Capivasertib311
- biopsy911
- Blood test1111
- Darolutamide711
- Biopsy Procedure511
- Adalimumab310
- Empagliflozin610
- Enfortumab Vedotin310
- FOLFOX910
- Isatuximab710
- Entrectinib310
- Eribulin310
- Giredestrant310
- Iberdomide510
- Dacarbazine410
- Ifosfamide610
- Orforglipron510
- Pertuzumab410
- No Intervention: Observational Cohort1010
- Surgery610
- Observational810
- Dato-DXd410
- Placebo Administration410
- standard care710
- TACROLIMUS610
- Ustekinumab310
- ANAKINRA89
- Nipocalimab79
- Placebo Oral Tablet59
- Sotorasib59
- Tucatinib39
- Afimkibart69
- Adagrasib79
- Filgotinib59
- Selinexor9
- Panitumumab89
- Tezepelumab49
- Polatuzumab vedotin39
- Bone Scan79
- Alectinib39
- normal saline79
- Sample collection99
- Virtual Reality79
- Radiation59
- Tislelizumab69
- Aspirin59
- KarXT99
- Retatrutide29
- Psilocybin69
- Zanidatamab68
- Efgartigimod PH20 SC38
- ianalumab28
- Rescue medications58
- Tarlatamab28
- Linvoseltamab88
- Encorafenib48
- Luspatercept48
- Alpelisib38
- not applicable, observational study88
- Saline68
- Prednisone/prednisolone78
- Pulmonary vein isolation78
- Odronextamab68
- Blinatumomab78
- Echocardiography Test68
- Multigated Acquisition Scan58
- SBRT48
- Apixaban48
- Cagrilintide28
- Ramucirumab38
- DASATINIB48
- IMFINZI 50 mg/mL concentrate for solution for infusion.68
- IPTACOPAN58
- MITAPIVAT28
- Dapagliflozin47
- folinic acid47
- Hydrocortisone57
- Sacituzumab Govitecan67
- Trifluridine-Tipiracil47
- Tulisokibart47
- Busulfan57
- Calderasib77
- LHRH Agonist17
- Sham (No Treatment)77
- Amlitelimab7
- Zimberelimab7
- Cardiac MRI47
- deucrictibant67
- Echocardiogram77
- Elotuzumab37
- MRI scan57
- PET-MRI67
- Platinum-based chemotherapy37
- Surovatamig77
- Teriflunomide17
- Bariatric surgery67
- Biological collection77
- Blood sample collection77
- Cognitive assessment67
- Diet77
- Inclisiran47
- Lumbar puncture67
- Secukinumab17
- Standard of Care (SOC)57
- Stereotactic Ablative Radiotherapy37
- ADT27
- Binimetinib57
- Etentamig57
- Sonelokimab37
- Sparsentan57
- NNC0487-011167
- The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.17
- Corticosteroids37
- Divarasib47
- Questionnaire and Physical Exam77
- Atogepant47
- Belimumab67
- Benralizumab37
- Temozolomide (TMZ)57
- Lazertinib27
- Tiragolumab27
- Rivaroxaban47
- Datopotamab deruxtecan27
- Depemokimab47
- Rilzabrutinib57
- Saruparib67
- Brentuximab vedotin36
- Cetrelimab16
- Gemcitabine + cisplatin16
- Indocyanine green56
- Patritumab Deruxtecan56
- Pemetrexed + carboplatin16
- Placebo IV46
- Sotatercept26
- The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date46
- Trastuzumab Emtansine16
- Lunsekimig56
- Camizestrant46
- FOLFIRI66
- Elecoglipron66
- Breath test56
- Sham46
- 5-fluorouracil (5-FU)66
- Inulin66
- Ipatasertib26
- Brenipatide66
- Pembrolizumab (KEYTRUDA®)46
- APG77736
- Crizotinib26
- Sacituzumab Govitecan-hziy16
- PREHABILITATION56
- Vinblastine46
- Domvanalimab6
- Vedolizumab56
- Observational study66
- Non-interventional46
- Lutikizumab16
- XBD17366
- Amoxicillin36
- Venepuncture46
- Whey protein56
- Ezabenlimab16
- Routine care66
- Stereotactic Body Radiotherapy36
- AZD012066
- Exercise Training66
- levoleucovorin36
- Maridebart cafraglutide46
- Neuropsychological tests56
- Non-Interventional Study56
- Placebo Control56
- Sham procedure26
- Standard treatment56
- Telisotuzumab Adizutecan46
- Time restricted eating66
- vincristine sulfate6
- AZD139036
- frexalimab36
- Mosunetuzumab46
- Zanzalintinib56
- Risdiplam56
- Transcranial direct current stimulation66
- 5-FU16
- Azacitidine (AZA)56
- Remibrutinib26
- Bone Marrow Aspiration26
- Melphalan46
- Intensity-Modulated Radiation Therapy26
- Ceralasertib26
- Zilovertamab vedotin56
- Dexmedetomidine66
- JNJ-7724211316
- Ketamine hydrochloride46
- Lebrikizumab36
- riliprubart66
- Axitinib5
- barzolvolimab35
- Elacestrant45
- Mepolizumab15
- Not provided at time of registration5
- Pemetrexed + cisplatin15
- vicadrostat45
- Itraconazole45
- Imatinib45
- Golcadomide25
- Androgen Deprivation Therapy (ADT)35
- Placebo Comparator45
- Nerandomilast35
- Vemurafenib25
- AZD98335
- Nivolumab + Relatlimab45
- Ravulizumab25
- Zongertinib35
- Radiofrequency ablation45
- Vehicle Cream45
- Rosuvastatin45
- Brachytherapy25
- BCG35
- Regorafenib25
- Standard Care (in control arm)45
- Placebo tablet35
- Ifinatamab deruxtecan45
- Futibatinib35
- Exercise Intervention45
- Active Surveillance35
- Inebilizumab45
- Survodutide35
- Furmonertinib5
- Colonoscopy55
- Momelotinib55
- Pegcetacoplan25
- Anifrolumab45
- Liver biopsy45
- mycophenolate mofetil55
- radical prostatectomy15
- Saliva sample25
- 177Lu-PSMA-61725
- Aerobic exercise45
- Botulinum toxin type A15
- daraxonrasib55
- Intismeran autogene25
- Dietary Intervention35
- Emicizumab35
- Interview45
- Magnetic Resonance Imaging (MRI)55
- Percutaneous coronary intervention45
- Photobiomodulation55
- Physiotherapy45
- Quality of life questionnaires35
- Relatlimab35
- revumenib35
- Smartwatch45
- Urine sample35
- Transthoracic echocardiogram45
- Elritercept55
- Opevesostat55
- Placebo (matched to NNC0487-0111)45
- Tebentafusp45
- Lecanemab15
- Supportive care measures35
- Tranexamic acid45
- Transcranial Magnetic Stimulation45
- Obexelimab15
- Selumetinib15
- ASTX72735
- Atomoxetine35
- Capmatinib35
- Cobimetinib15
- Patient Observation25
- Stereotactic Body Radiation Therapy15
- Ultrasound35
- Bone Marrow Biopsy15
- Oleclumab15
- Norepinephrine55
- Mavacamten25
- KarX-EC55
- Felzartamab35
- BLEOMYCIN25
- CEFAZOLIN45
- Colchicine45
- Mitomycin-C35
- Placebo capsule35
- Ritlecitinib15
- Route of administration: Oral use45
- [177Lu]Lu-NeoB14
- zolbetuximab24
- [68Ga]Ga-NeoB14
- AAA61724
- Anvumetostat4
- Bosutinib24
- Epoetin alfa24
- Hydroxychloroquine34
- JNJ-7893480424
- mezigdomide34
- Omeprazole34
- Sacituzumab Govitecan-hziy (SG)14
- Tozorakimab34
- Bleximenib34
- AFLIBERCEPT34
- Claseprubart24
- Pegylated liposomal doxorubicin44
- ENOXAPARIN34
- Efanesoctocog alfa24
- Plozasiran Injection4
- CGT948644
- AZD530514
- Itepekimab (SAR440340)4
- Blood tests44
- SYT-51044
- Cabazitaxel34
- Waiting list34
- Icotrokinra34
- Prostate biopsy14
- visugromab (CTL-002)34
- Vosoritide24
- BHV-700024
- Azithromycin34
- CTx00124
- disitamab vedotin14
- Gemcitabine + carboplatin4
- AZD090124
- Optimal Medical Therapy24
- Pegylated liposomal doxorubicin (PLD)34
- Pelabresib34
- Finerenone (Kerendia, BAY94-8862)34
- Hydroxyurea34
- T-DXd24
- Tafasitamab4
- Ivosidenib44
- transthoracic echocardiography44
- DOR/ISL4
- RCT21004
- LY353703144
- Escitalopram34
- Efgartigimod IV34
- Transcranial Direct Current Stimulation (tDCS)44
- [177Lu]Lu-DOTA-TATE14
- Spirometry24
- Povetacicept24
- ECG44
- INZ-7014
- Aortic valve replacement34
- Standard of care treatment34
- Skin biopsy34
- Povorcitinib14
- Ofatumumab24
- Nilotinib14
- Mitapivat-matching placebo4
- givinostat34
- Fianlimab4
- Electrocardiogram34
- education34
- Bulevirtide14
- Axicabtagene Ciloleucel24
- ALXN222014
- Dabrafenib24
- Datopotamab deruxtecan (Dato-DXd)44
- Electrical Impedance Tomography24
- Lutathera24
- Placebo semaglutide14
- Placebo supplement34
- Repetitive Transcranial Magnetic Stimulation (rTMS)44
- Idelalisib24
- Zasocitinib34
- Biofeedback training44
- Nirogacestat14
- Blood collection34
- blood draw34
- Catheter ablation24
- Conduction System Pacing44
- glucose24
- goserelin24
- Imlunestrant14
- LEUCOVORIN CALCIUM4
- Lung ultrasound44
- No interventions.44
- Non-invasive ventilation34
- Pacritinib34
- Paltusotine4
- Placebos44
- Protein supplement34
- psilocybin (25 mg)44
- Quality of Life44
- rapcabtagene autoleucel4
- remdesivir44
- stereotactic body radiotherapy (SBRT)34
- Treatment as Usual (TAU)34
- Belrestotug4
- Sertraline34
- Budigalimab24
- SODIUM CHLORIDE44
- Pegaspargase14
- Sotagliflozin34
- Nemtabrutinib34
- Pembrolizumab (+) Berahyaluronidase alfa24
- Pembrolizumab/Quavonlimab4
- Tecentriq 1 200 mg concentrate for solution for infusion34
- Placebo for Atogepant14
- Tepotinib24
- The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full deta4
- RO72042394
- Rucaparib14
- Saline Nasal Spray44
- Satralizumab24
- Faricimab4
- TAR-2004
- Venetoclax (VEN)34
- Sorafenib4
- Selpercatinib4
- YERVOY 5 mg/ml concentrate for solution for infusion, OPDIVO 10 mg/mL concentrate for solution for infusion.24
- MEDI47364
- Caffeine34
- XEN110134
- Belumosudil34
- BMS-98650444
- Chemotherapy drug44
- Cilta-cel4
- Daunorubicin34
- Dactinomycin24
- RPT90444
- Monalizumab14
- Lurbinectedin14
- Degarelix14
- Cemdisiran24
- Apremilast34
- Tazemetostat14
- Sirolimus34
- Pozelimab24
- Adjuvant therapy4
- Clozapine34
- Encorafenib, binimetinib24
- Forxiga 10 mg film-coated tablets24
- garadacimab34
- Gemtuzumab ozogamicin24
- Golexanolone4
- Methylphenidate34
- Nemolizumab24
- OPDIVO 10 mg/mL concentrate for solution for infusion.34
- Rapamune 1 mg/mL oral solution34
- Pazopanib4
- Ranibizumab24
- Vutrisiran23
- AZD6738 (ceralasertib)23
- CAPOX33
- EV23
- evorpacept13
- FLOT chemotherapy23
- Fludeoxyglucose (18F)33
- Radiprodil13
- obrixtamig33
- Phesgo23
- Placebo matching Vicadrostat23
- Sham Comparator23
- Waitlist33
- Vehicle23
- Leniolisib3
- LP35213
- BGB-1141733
- Acalabrutinib (ACP-196)3
- CYB00323
- Trontinemab13
- ALXN18503
- ENTR-601-4433
- Probiotic33
- Mocertatug rezetecan33
Showing the top 600 of 1,000 matches — refine your search to narrow down.